Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
about
Crystal structure and silica condensing activities of silicatein α–cathepsin L chimerasImpact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injuryHistological evaluation of the biocompatibility of polyurea crosslinked silica aerogel implants in a rat model: a pilot studyMultifunctional Au@mSiO2/rhodamine B isothiocyanate nanocomposites: cell imaging, photocontrolled drug release, and photothermal therapy for cancer cells.Lipid-mediated DNA and siRNA Transfection Efficiency Depends on Peptide HeadgroupBiomimetic Intrafibrillar Mineralization of Type I Collagen with Intermediate Precursors-loaded Mesoporous CarriersHaemocompatibility evaluation of silica nanomaterials using hemorheological measurements.Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticlesBiocompatibility, endocytosis, and intracellular trafficking of mesoporous silica and polystyrene nanoparticles in ovarian cancer cells: effects of size and surface charge groups.Nanostructured porous Si-based nanoparticles for targeted drug deliveryPeptide-based imaging agents for cancer detection.Utilization of Enzyme-Immobilized Mesoporous Silica Nanocontainers (IBN-4) in Prodrug-Activated Cancer Theranostics.Aerosol route to functional nanostructured inorganic and hybrid porous materials.The complexity of mesoporous silica nanomaterials unravelled by single molecule microscopy.Silicon-polymer hybrid materials for drug delivery.Spherical silica micro/nanomaterials with hierarchical structures: synthesis and applications.Nanomedicines for cancer therapy: state-of-the-art and limitations to pre-clinical studies that hinder future developments.Shape matters when engineering mesoporous silica-based nanomedicines.Controlled release and intracellular protein delivery from mesoporous silica nanoparticles.Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo.An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system.Fluorescent dye-doped silica nanoparticles: new tools for bioapplications.Uniform magnesium silicate hollow spheres as high drug-loading nanocarriers for cancer therapy with low systemic toxicity.Mesoporous silica nanorods for improved oral drug absorption.Gold Nanorod Array Biochip for Label-Free, Multiplexed Biological Detection.Aminopropyl groups of the functionalized Mobil Crystalline Material 41 as a carrier for controlled diclofenac sodium and piroxicam delivery.Utility and Potential Application of Nanomaterials in MedicineFunctional Nanomaterials for Multifarious NanomedicineAuditory disorders and future therapies with delivery systems
P2860
Q27650199-89C9FB08-6327-4A4A-81BB-686B918EFCB5Q28387533-B2B45B07-0A41-49C4-A132-A194FE027C3EQ28484322-E8E7EE0B-1468-4B1D-8C77-99AB9849E6CDQ34461970-061031B6-BFD6-4243-8C53-0B4ADC48BF4FQ35082289-0CD33113-30D9-48FB-BE19-603F19E730C3Q35693437-EA698AD3-85E1-4584-B86B-F9FC1D9A9554Q35789664-3C03002D-DA35-44C7-BBD9-D04F80B920F1Q35941391-22EA7461-81CD-4696-8E5C-7A13162691AFQ36161045-4FDBB3F7-464B-4DDF-A575-99A1407CFE00Q36597461-1356472D-8C72-411F-8459-ED4251E5A804Q37585965-82C2BECA-F1C5-4EDD-B090-125A004BB6EEQ37638585-3917B341-0134-4DD4-8219-F61C232449DBQ37801884-DB60D6A9-EFAE-49D3-BBCF-D71CE1C360D1Q37843700-235473C8-73AD-49A1-980A-B88212EDE933Q37855825-CA8AFED0-B95E-4538-9268-68A992009B74Q37932417-F4837EE7-5498-4735-A78A-FEF750615672Q38247299-873A926E-22BC-4577-9F06-8F09D5A74D20Q38714438-068390F5-1D1C-4F36-829E-D9B59E1F5B4FQ38782837-7134F75F-7A77-434E-B4C1-76F197DCD219Q39176123-0F4519CE-0F20-4CE6-89E0-E5BC8ABDAEACQ45887696-276CDBAB-B3CE-4D01-B345-858A807DE90BQ45934786-CF56F85F-FDA4-4600-AFDF-FA4479484B44Q48704117-FA5030D9-385C-483B-A0AA-2CE9C63099B0Q50234830-646BEE35-295B-4920-B530-3CE9E0C4440DQ50508962-0414AAA2-C532-4FFD-9FF0-0F18926E3618Q50851314-9BCCB426-2B64-453C-B4AC-4DF667F577E6Q55333272-0165B049-D656-41B4-A51B-5A17C0E8DF6FQ57340460-47965663-50FD-41DC-8155-3322C30A05B3Q57340480-773F98F4-91F3-44AA-A6FD-E53BBF4506C0Q58593680-B617F3DA-B07E-4BA3-A84D-6A533F1DBB95
P2860
Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
@en
type
label
Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
@en
prefLabel
Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
@en
P2093
P2860
P356
P1433
P1476
Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
@en
P2093
Brian G Trewyn
Supratim Giri
Victor S Y Lin
P2860
P304
P356
10.2217/17435889.2.1.99
P577
2007-02-01T00:00:00Z